PYC pyc therapeutics limited

trading halt ???, page-21

  1. 664 Posts.
    Financials
    �X Net cash position as at February 2011 was A$2.2m
    �X Cash burn - Cash burn in FY10 (y/e 30 June) of AU$3.8m
    �X FY10 result �V PYC reported a FY10 net loss of A$4.6m. Key items included revenue of
    A$0.4m, contract research costs of A$1.9m, and employee expenses of A$1.4m. Net
    operating cash outflow was A$3.6m and cash at 30 June was A$1.3m.
    �X 1H11 result �V PYC reported a 1H11 net loss of A$0.9m. Key items included revenue of
    A$1.7m, contract research costs of A$1.1m, and employee expenses of A$0.7m. Net
    operating cash outflow was A$1.5m and cash at 31 December was A$1.8m. PYC also has
    convertible notes that were issued at nil interest and mature on 30 April 2011. Previously the
    notes have been discounted at a rate of 10% pa to calculate fair value at each balance date.
    The notes are redeemable by the Company by payment of $1,7m, are convertible by
    noteholders before the maturity date at $0.05 per share or convert at maturity at $0.04 per
    share. Conversion at maturity would result in the issue of 33,500,000 shares or 10.6% of the
    issued capital after the conversion.
    �X Guidance �V PYC��s objective is to achieve cash sustainability in 2 years
    �X Capital Structure �V 283m Ordinary shares, 64m options and 1.3m convertible notes (convert
    to 27m shares).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.20
Change
0.040(3.45%)
Mkt cap ! $699.9M
Open High Low Value Volume
$1.19 $1.20 $1.18 $97.44K 81.86K

Buyers (Bids)

No. Vol. Price($)
1 5000 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.20 19651 3
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.